11.60
5.94%
0.65
Cullinan Therapeutics Inc Azioni (CGEM) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
-
|
- | -0.44 | - | - |
Operating Expenses
|
5.49%
42.99
|
45.48 | 44.80 | 37.60 | 62.76 |
Operating Income/Loss |
5.49%
-42.99
|
-45.48 | -45.24 | -37.60 | -62.76 |
Income/Loss From Continuing Operations Before Tax |
5.91%
-37.34
|
-39.69 | -39.18 | -32.21 | -58.14 |
Income/Loss From Continuing Operations After Tax |
46.07%
-37.34
|
-25.56 | -39.18 | -32.21 | -58.14 |
Net Income/Loss
|
46.07%
-37.34
|
-25.56 | -39.18 | -32.21 | -58.14 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
89.09%
-0.192
|
-1.76 | - | - | -0.179 |
Basic Average Shares |
10,141%
43.01
|
0.42 | 42.73 | 39.95 | 40.68 |
Diluted Average Shares |
10,141%
43.01
|
0.42 | 42.73 | 39.95 | 40.68 |
Basic Earnings Per Share |
59.26%
-0.86
|
-0.54 | -0.91 | -0.82 | -1.42 |
Diluted Earnings Per Share |
59.26%
-0.86
|
-0.54 | -0.91 | -0.82 | -1.42 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):